Showing results (31-40 of 38) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|September 6, 2020
Efficacy and safety of micafungin in empiric and D-index-guided early antifungal therapy for febrile neutropenia; A subgroup analysis of the CEDMIC trialShun-Ichi Kimura, Yoshinobu Kanda, Masaki Iino, et al.
Journal of Medical Case Reports|November 22, 2025
Clonal identification and homology differentiate primary central nervous system lymphoma from non-central nervous system lymphoplasmacytic lymphoma: a case reportYuko Tanaka, Nahoko Furuya, Seiichi Okabe, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|August 2, 2023
Clinical significance of late CMV disease in adult patients who underwent allogeneic stem cell transplantHiroaki Shimizu, Yuho Najima, Shinichi Kako, et al.
Bone Marrow Transplantation|January 9, 2021
Stopping tyrosine kinase inhibitors started after allogeneic HCT in patients with Philadelphia chromosome-positive leukemiaHideki Nakasone, Shinichi Kako, Takehiko Mori, et al.
Annals of Hematology|August 6, 2021
Pre-conditioning intervention in patients with relapsed or refractory acute lymphoblastic leukemia who underwent allogeneic hematopoietic cell transplantation: a KSGCT multicenter retrospective analysisTakayoshi Tachibana, Junya Kanda, Takuma Ishizaki, et al.
Transplantation and Cellular Therapy|June 25, 2021
Novel Indicators of Transplant Outcomes for PhALL: Current Molecular-Relapse-Free SurvivalHideki Nakasone, Shinichi Kako, Takayoshi Tachibana, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 22, 2020
Outcomes and Prognostic Factors for Patients with Relapsed or Refractory Acute Lymphoblastic Leukemia Who Underwent Allogeneic Hematopoietic Cell Transplantation: A KSGCT Multicenter AnalysisTakayoshi Tachibana, Junya Kanda, Takuma Ishizaki, et al.
Transplantation and Cellular Therapy|October 2, 2020
Clinical Benefits of Preconditioning Intervention in Patients with Relapsed or Refractory Acute Myelogenous Leukemia Who Underwent Allogeneic Hematopoietic Cell Transplantation: A Kanto Study of Group for Cell Therapy Multicenter AnalysisTakayoshi Tachibana, Junya Kanda, Takuma Ishizaki, et al.
Pageof 4